Introduction
piece-wise linear function that made 99 evenly spaced quantiles agree with the corresponding quantiles on the standard. Normalized expression levels were log-transformed by mapping x to log(max(x+100,0)+100). Fold changes were computed as the ratio of group means, after first replacing means less than 100 by 100. One way analysis of variance models were fit to log-transformed data and pairs of groups compared by the resulting contrast tests. 9996
probe-sets in the correct orientation were analyzed, the remainder being assay controls or sequences with reversed orientations.
Ribonuclease protection assay (RPA)
RPA was performed using RiboQuant RPA kit (PharMingen, San Diego, CA) according to the manufacturer's instructions. The template sets we used include three categories of genes including caspase families (mAPO-1), chemokines (mCK-5b), and murine customized probe sets containing ICAM-1 and VCAM-1. The sample loading was normalized by the housekeeping gene, L32, included in each template set. RPA was performed on 10 µg of total RNA hybridized with probes labeled with α-32 P UTP. After digestion of ssRNA, the RNA pellet was solubilized and resolved on 6% polyacrylamide gels. Gels were exposed by phosphorimaging and analyzed on a PhosphoImager system, Storm 860 (Amersham 8 only.
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Immunohistochemistry
Livers and spleens fixed in 10% formalin before being embedded in paraffin were subsequently deparaffinized and rehydrated. The tissue sections were heated at 95°C for 25 min in Antigen Retrieval Citra solution (BioGenex, San Ramon, CA) to rescue antigen for ICAM-1 staining. Next, they were treated with either a goat anti-mouse ICAM-1 primary Ab (Santa Cruz Biotechnology, Santa Cruz, CA) at 1:500 dilution or a rabbit anti-mouse IFN-γ primary Ab (Biosource international, Camarillo, CA) at 1:250 dilution. Antibody binding was visualized by either secondary anti-goat or anti-rabbit Vectastain ABC Elite kits (Vector Laboratories, Burlingame, CA) with diaminobenzidine as substrate followed by light counterstaining with methylgreen.
Results

Development of hepatic GVHD after BMT
We first studied the histological changes of hepatic GVHD in a well established mouse BMT system 7 in which GVHD is induced by both MHC and minor histocompatibiliy antigens differences between donor and recipient. B6D2F1 mice (H-2 b/d ) received 13 Gy TBI and were injected with 5 X 10 6 BMCs with 2 X 10 6 splenic T cells from either allogeneic B6 donor or syngeneic B6D2F1 donors. Livers were harvested at both day 7 and day 35 after BMT and cut into two pieces, one for histological examination and the other for RNA extraction. As shown in Table 1 , histologic GVHD was quantitated for sixteen individual parameters. Damage at day 35 was readily apparent in all four major categories (portal triads, bile ducts/ductules, vessels, and hepatocytes), whereas syngeneic controls without GVHD were identical to naïve, untransplanted recipients. We also evaluated livers at day 7, a time when acute GVHD is histologically evident in other visceral organs such as in the gastrointestinal tract.
7
As expected and in contrast to the findings on day 35, liver specimens at day 7 after BMT were identical to untransplanted controls and did not show significant evidence of acute GVHD (Table 1) .
10
only.
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More than half of the genes which differed at one time point showed the evidence of similar changes at the other time points. Of 95 probe-sets altered (p<0.01, FC>3.5) at day 7, only 24 failed to yield a difference (p<0.05) at day 35, whereas for the 87 probe-sets altered at day 35, 41 were not different (p<0.05) at day 7.
The list of genes that differed by 2 fold or greater giving p<0.01, which contains 356 probe-sets and thus may cover broad range of GVHD-related genes is available on the web (http://dot.ped.med.umich.edu:2000/pub/BMT/index.html).
Ribonuclease protection assay of genes represented in the oligonucleotide array
To validate the results of oligonucleotide array analysis, expression levels of six individual genes from three different categories (adhesion molecules, chemokines, and caspases) were analyzed by RPA (Fig. 1) . Regression analysis of these six separate genes demonstrated a close correlation between these two methods of measurement at both time points analyzed 12 only.
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Immunohistochemistry of ICAM-1
The changes in gene expression were further evaluated by immunohistochemistry of ICAM-1 protein. Increased gene expression of ICAM-1 was detected by RPA and microarray as described below on both day 7 and day 35 after allogeneic BMT. Using the immunohistochemical techniques described in methods, increased expression of ICAM-1 protein was observed in portal vein endothelium, and sinusoidal endothelial cells in the liver after allogeneic BMT animal (Fig. 2) .
Patterns of gene expression change following BMT
We divided genes that were up or downregulated after allogeneic BMT into nine different 
Inducible by IFN-γ
Of the nine different categories evaluated, the category where the largest number of genes was upregulated at day 7 was that of IFN-γ-inducible genes, such as transcription factors and signaling proteins (Figure 3 ). For example, the expression of signal transducer and activator of transcription-1 (STAT1), which translocates to nucleus upon phosphorylation by IFN-γ receptor, was increased almost nine fold on day 7 after allogeneic BMT. Activated STAT1 sequentially promotes the expression of a number of transcription factors such as interferon regulatory factor-1 (IRF-1), IRF-7, and IFN consensus sequence binding protein (ICSBP), 10 all of which were also increased at this time. Interestingly, we could not detect increased expression of the IFN-γ gene itself although many IFN-γ -inducible genes were upregulated in the liver at day 7. We therefore performed immunostaining for IFN-γ at day 7 after BMT in both the liver and spleen. As shown in Figure 3 , IFN-γ protein was not detected in the liver although it was clearly evident in the spleen after allogeneic BMT, consistent with earlier observations demonstrating expansion of IFN-γ secreting donor T cells by day 7 after BMT in this model. Ifi204 and Ifi202A, both of which inhibit cell proliferation, were also increased and may partially mediate the antiproliferative effect of the IFN-γ. 15 Similarly, suppressor of cytokine signaling-1 (SOCS1) inhibits Janus kinase (JAK) activities and negatively regulates signaling of cytokines such as IFNs, IL-2, IL-4, IL-6, IL-13, leukemia-inhibitory factor, stem cell factor, and erythropoietin.
16
The Fas/Fas ligand (FasL) pathway is one of the principle components of T cell cytotoxicity.
17
The vast majority of genes in this category showed increased expression at day 7, but did not remain elevated in the liver when histologic damage was evident (day 35).
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Antigen presentation
Mice possess two classical MHC class II isotypes, the I-A and I-E molecules, each composed of α and β chains.
18
In the livers of allogeneic BMT recipients, I-Aα, I-Aβ, I-Eα, and I-Eβ were all upregulated at day 7 and several genes remained elevated at day 35, whereas no increase of MHC class I gene expression was observed. Gene expression was also increased for low-molecular mass polypeptide 2 (LMP2) and LMP7, proteasome subunits that enhance the production of peptides capable of association with MHC class I molecules.
19
The transporter associated with antigen processing 1 and 2 (TAP1 and 2) genes, which translocates peptides generated by proteasomes into endoplasmic reticulum, was also increased. In addition, there was increased expression of MHC-DMs, whose presence in lysosomes facilitate the assembly of MHC class II molecules with peptides from exogenous proteins. 18, 20 Thus, genes related to peptide processing for both MHC class I and class II were upregulated.
Leukocyte trafficking
The majority of leukocyte trafficking-related genes involving adhesion molecules and chemokines were upregulated after allogeneic BMT on both day 7 and day 35. There was increased expression of several chemokines that activate leukocyte cell-surface integrins, (Table 1) .
Lymphoid effectors
As expected, many T cell antigens such as TCR, CD7, CD45, and CD52 were upregulated in livers after allogeneic BMT. Most genes in this category were predominantly expressed at day 35, again consistent with the infiltration of effector cell observed at this time (Table 1) .
Myeloid and inflammatory effectors
Antigens or cell surface receptors expressed in myeloid cells and genes related to their functions were upregulated in livers after allogeneic BMT. Marco, a member of scavenger receptor family, is induced by LPS, 28 an inflammatory molecule that is found in the systemic circulation in this GVHD model. 43 and were upregulated in the liver after allogeneic BMT.
Intestinal trefoil factor 3 (Tff3) is induced during the biliary disease in the liver, 44 and facilitates tissue repair. 45, 46 S100 family proteins regulate cytoskeleton constituents and modulate cell growth and differentiation at the site of chronic inflammation. 47 Among S100
family proteins, S100a8 and S100a9 form heterodimers that regulate several aspects of inflammatory response and their expression are restricted to neutrophils, activated macrophages and endothelial cells. 48 RhoN, 49 a member of Rho family GTPases, controls cytoskelton organization through stimulating the polymerization of actin, and may thus control cell growth and differentiation.
Acute phase proteins
As a consequence of the inflammation that occurs during GVHD, hepatocytes produce a number of acute phase proteins such as protease inhibitors, amyloid, orosomucoids, and metallothioneins. For
Metabolism and endocrine function
In contrast to all the other categories, the majority of genes associated with metabolism and endocrine functions were downregulated after allogeneic BMT, probably reflecting the stress response of hepatic tissue. Downregulation of these genes is known to be caused by hepatotoxins such as LPS and thioacetamide. 55 Interestingly, these genes were primarily downregulated at day 7, demonstrating that stress in hepatic tissue was evident long before there was histologic evidence of hepatic damage. 
ESTs and genes with unknown function
Discussion
GVHD is an alloimmune response that begins when donor T cells recognize host alloantigens.
Since host APCs are critical in this process, 3,5 the alloimmune response may require secondary lymphoid organs, which provide the proper environment for APCs to interact with naïve T cells. IFN-γ production is an early event in the cytokine cascade of GVHD with peak serum levels by day 7 after allogeneic BMT.
58-60
We detected significant expression of IFN-γ in the spleen, but not the liver, consistent with a previous kinetic study of organ-specific cytokine expression in GVHD demonstrating that the spleen is the principal source of inflammatory cytokines including IFN-γ and TNF-α. 61 Other secondary lymphoid organs are also sites where donor T cells encounter host alloantigens because removal of recipient's spleens does not prevent GVHD in this model. A consistent observation in hepatic GVHD is the aberrant expression of MHC class II molecules on bile duct epithelium, a site of lymphocytic infiltration. [63] [64] [65] [66] We found increased expression of MHC class II molecules before the infiltration of effector cells, consistent with the hypothesis that increased MHC class II expression on bile duct epithelium might render it 
68-70
It should be noted that disruption of ICAM-1 gene in the recipient does not improve the histological findings of the liver, suggesting that host ICAM-1 expression is not necessary for the development of hepatic GVHD. 71 Third, IFN-γ stimulates the production of inflammatory chemokines which control the migration of effector cells toward sites of inflammation.
22,23
Early after allogeneic BMT, we found increased expression of inflammatory chemokines, including Mig and IP-10, CXCR3 ligands. Upregulation of Mig and IP-10 was also part of the early pathogenesis of allograft cardiac rejection. 72, 73 The exact role of those inflammatory chemokines in the initiation of hepatic GVHD is currently unknown.
In contrast to the early upregulation of most inflammatory chemokines, RANTES, a CCR5 ligand, was significantly upregulated at day 35 with the infiltration of effector cells in the liver. In a non-irradiated GVHD model, MIP-1α, another ligand for CCR5, was upregulated in the liver 2 weeks after BMT even though the expression of RANTES was unchanged. 74 In that study, the administration of mAbs to CCR5 prevented the accumulation of T cell to the liver. 74 Similar late induction of RANTES has been observed in experimental models of the heart 75 and lung 76 allograft rejection, suggesting RANTES-CCR5 interaction might also be a suitable therapeutic target for these transplanted organs.
Fourth, IFN-γ increases Fas expression in target tissues. 77 Accumulating evidence suggests that Fas-mediated T cell cytotoxicity plays an essential role in the development of hepatic GVHD. Use of FasL deficient donor mice 78 and administration of anti-FasL mAb 79 can significantly reduce hepatic GVHD, whereas Fas deficient recipients are resistant to the induction of GVHD specifically in the liver.
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Our study demonstrated that Fas was upregulated at day 7 in the liver, suggesting liver becomes vulnerable to Fas-L mediated CTL attack prior to hepatic damage.
Lastly, IFN-γ renders monocytes and macrophages sensitive to endogenous LPS, resulting in the increased production of TNF-α and IL-1, 7,81 which share overlapping inflammatory properties in GVHD pathophysiology. 82 In addition to proinflammatory activity it shares with IFN-γ, TNF-α can directly induce apoptosis or necrosis 83 in target tissue.
TNF-α-mediated cytotoxicity plays a crucial role in the development of intestinal GVHD. 79, 84 Recent studies have demonstrated that intensive blockade of TNF-α and IL-1 can prevent hepatic GVHD, probably limiting effector cell migration to the liver by the suppression of inflammatory chemokine production.
5
Although our results suggest that IFN-γ recruits effector cells to the liver during acute GVHD, lack of IFN-γ secretion by donors does not prevent the hepatic infiltration of lymphocytes. 85, 86 Similarly, IFN-γ knockout mice (GKO) can reject cardiac allografts. 87 Microarray analysis of GKO recipients in a cardiac allograft model reveals that some chemokines and their receptors such as MCP-1, MIP-1, SDF-1, C10, and CXCR4 were induced as efficiently as in normal recipients despite the absence of IFN-γ function even though the expression of Mig, IP-10, and RANTES was decreased in the heart. 88 It should be noted, however, that disruption of IFN-γ receptor gene in a transplanted heart can prevent cardiac allograft rejection, suggesting a critical role of IFN-γ-inducible genes in the alloresponse. 89 26 only.
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Systemic IFN-γ is clearly induced in many models of acute GVHD 61, 90 , but it is usually not observed in the plasma in this model later than two weeks after transplant (data not shown).
Nevertheless, the lack of IFN-γ gene expression in the liver on day 35 at the time of tissue damage was curious, although several explanations are possible. The mononuclear cell infiltration of the liver in GVHD is usually highly localized and confined to very specific locations such as the periportal space. The sampling method used here did not target such areas specifically, and the amount of infiltrate present in any sample is thus likely to be small.
Infiltrates are also likely to be composed of several cell types which could further dilute the For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From histopathologic damage is evident. A more detailed kinetic analysis of the samples using techniques such as laser capture microdissection will be required to address this issue.
Based on the studies of murine GVHD directed selectively to class I vs. class II differences,
CD4
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